Table 3.
Clinical characteristics of COVID-19 in different age ranges.
| Age range | Non-old (young and middle age), patient no. | Old age, patient no. | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
Total n = 137 |
Moderate n = 77 |
Severe n = 41 |
Critically severe n = 19 |
P-Valved |
Total n = 167 |
Moderate n = 63 |
Severe n = 73 |
Critically severe n = 31 |
|
| Female | 72 (52.55%) | 45 (58.44%) | 19 (46.34%) | 8 (42.11%) | 0.52 | 94 (56.29%) | 40 (63.49%) | 42 (57.53%) | 12 (38.71%) |
| Male | 65 (47.44%) | 32 (41.56%) | 22 (53.66%) | 11 (57.89%) | 73 (43.71%) | 23 (36.51%) | 31 (42.47%) | 19 (61.29%) | |
| SIGNS AND SYMPTOMS AT ADMISSION | |||||||||
| Fever | 77 (56.20%) | 43 (55.84%) | 28 (68.29%) | 6 (31.58%) | 0.91 | 95 (56.89%) | 32 (50.79%) | 52 (71.23%) | 11 (35.48%) |
| Cough | 58 (42.34%) | 36 (46.75%) | 17 (41.46%) | 5 (26.31%) | 0.58 | 76 (45.51%) | 27 (42.86%) | 39 (53.42%) | 10 (32.26%) |
| Dyspnea | 9 (6.57%) | 6 (7.79%) | 2 (4.88%) | 1 (5.26%) | 0.11 | 20 (11.98%) | 7 (11.11%) | 8 (10.96%) | 5 (16.13%) |
| Fatigue | 19 (13.87%) | 11 (14.29%) | 6 (14.63%) | 2 (10.53%) | 0.09 | 13 (7.78%) | 4 (6.35%) | 8 (10.96%) | 1 (3.23%) |
| Chest distress | 10 (7.30%) | 7 (9.09%) | 1 (2.44%) | 2 (10.53%) | 0.75 | 14 (8.38%) | 10 (15.87%) | 2 (2.74%) | 2 (6.45%) |
| Expectoration | 6 (4.38%) | 2 (2.60%) | 3 (7.32%) | 1 (5.26%) | 0.33 | 4 (2.40%) | 1 (1.59%) | 2 (2.74%) | 1 (3.23%) |
| Sore throat | 3 (2.19%) | 1 (1.30%) | 2 (4.88%) | 0 | 0.5 | 2 (1.20%) | 1 (1.59%) | 1 (1.37%) | 0 |
| Diarrhea | 2 (1.46%) | 1 (1.30%) | 1 (2.44%) | 0 | 0.82 | 3 (1.80%) | 0 | 3 (4.11%) | 0 |
| Asymptomatic | 19 (13.87%) | 13 (16.88%) | 6 (14.63%) | 0 | 0.62 | 20 (11.98%) | 10 (15.87%) | 10 (13.70%) | 0 |
| CHRONIC MEDICAL ILLNESS | |||||||||
| Hypertension | 18 (13.14%) | 5 (6.49%) | 11 (6.83%) | 2 (10.53%) | <0.01 | 65 (38.92%) | 21 (33.33%) | 34 (46.58%) | 10 (32.26%) |
| CAD | 4 (2.92%) | 1 (1.30%) | 3 (7.32%) | 0 | 0.01 | 17 (10.18%) | 5 (7.94%) | 10 (13.70%) | 2 (6.45%) |
| Diabetes | 7 (5.11%) | 3 (3.90%) | 2 (4.88%) | 2 (10.53%) | <0.01 | 33 (19.76%) | 11 (17.46%) | 16 (21.92%) | 6 (19.35%) |
| COPD | 1 (0.73%) | 1 (1.30%) | 0 | 0 | 0.1 | 6 (3.59%) | 1 (1.59%) | 4 (5.48%) | 1 (3.23%) |
| Renal failure | 12 (8.76%) | 1 (1.30%) | 9 (21.95%) | 2 (10.53%) | 0.95 | 15 (8.98%) | 1 (1.59%) | 11 (15.07%) | 3 (9.68%) |
| Malignancy | 2 (1.46%) | 1 (1.30%) | 1 (2.44%) | 0 | 0.45 | 1 (0.60%) | 0 | 1 (1.37%) | 0 |
P-value dindicates differences between old age and non-old age COVID-19 patients, P < 0.05 was considered statistically significant.